SARS-CoV-2's evolutionary capacity is mostly driven by host antiviral molecules https://www.biorxiv.org/content/10.1101/2023.04.07.536037v1?med=mas
SARS-CoV-2's evolutionary capacity is mostly driven by host antiviral molecules https://www.biorxiv.org/content/10.1101/2023.04.07.536037v1?med=mas